Japanese hospital to test new cancer therapy
2011 01 20
Medical researchers in Japan say they will start the world’s first clinical studies of a radiation therapy using accelerator-based neutron beams to kill cancer cells.
The National Cancer Centre in Tokyo and a Japanese medical equipment maker -- Cancer Intelligence Care Systems -- plan to start the studies using "boron neutron capture therapy (BNCT)" in three years, the centre said.
The BNCT is an innovative radiation treatment which kills cancer cells selectively without side-effects, but it requires a massive facility including a nuclear reactor to produce neutron beams.
By using a particle accelerator, which is cheaper, safer and smaller than a reactor, it will become feasible for a hospital to provide the therapy on actual patients, the centre told journalists Tuesday.
The centre hopes to try the special radiation therapy on patients with cancers that have been difficult to treat in conventional procedures, such as brain tumors and melanoma, it said.
Article from: google.com
The boron neutron capture therapy(BNCT) is a promising method of cancer treatment in principle, which kills cancer cells selectively by the use of cancer seeking boron compound and the neutron irradiation. Source
Boron neutron capture therapy for brain tumours
Boron neutron capture therapy (BNCT) is an experimental way of giving radiotherapy that has been used in trials with glioblastoma multiforme (grade 4 glioma). There are concerns that the treatment causes severe side effects, so trials continue in Europe and the USA. The trials are looking into using this treatment after surgery to try to reduce the risk of the brain tumours coming back.
BNCT is really a combination of treatment with boron and fast neutrons. Radiotherapy using neutrons can get rid of glioblastoma cells. Unfortunately, at the dose needed to do this, too much damage is caused to healthy brain tissue.
In BNCT, boron is injected into the bloodstream and collects in tumour cells. The next stage of the treatment is external radiotherapy with low energy neutrons. The boron molecules give off radiation within the brain tumour cells when the external neutron radiation hits them. This enhances the radiation dose by about 2 or 3 times. So, a lower dose of neutron radiotherapy can be given. This makes it less likely that the neutrons will cause damage.
Unfortunately, there have been reports of damage being caused by the boron in the brain. This was an unexpected complication and more research needs to be done to confirm or deny this. There are no trials for patients going on in the UK at the moment. BNCT research is going on here, but it is still at the pre-clinical (laboratory) stage. Hopefully, this will lead to an early phase clinical trial soon.
There is an early phase trial in the US for people with newly diagnosed glioblastoma multiforme. The trial is testing BNCT with a chemotherapy drug called temozolamide. Early phase trials look at side effects, doses and whether there seems to be a response for a particular cancer. It is only in later phase 3 trials that we can see if a new treatment works any better than an existing treatment. So it will be some years before we have any long term results for BNCT.
Article from: cancerhelp.org.uk
Radioactive Cancer Patients: Public Health Menace?
Cancer ’is purely man-made’ say scientists after finding almost no trace of disease in Egyptian mummies
Breakthrough for cancer-hit Tasmanian Devils
Socioeconomic status predicts survival of cancer patients
US War Crimes: Cancer Rate in Fallujah Worse than Hiroshima
Major Cancer Charity to Admit It Was Wrong About Suntanning
Sunscreen scam? We spend millions on protection, so why is skin cancer still on the rise?
Insurance company targets breast cancer victims; cancels policies without their knowledge
He’s in the Army now: Wife’s cancer prompts man to enlist
Sick of pink: Commodifying Cancer
Latest News from our Front Page
Footage of Killer Machete ‘Terrorist’ Attack in Woolwich, East London - Major Inconsistencies in the video footage
2013 05 24
Red Ice Creations: The following analysis of the killing in Woolwich, London is provided by many sources. Many different opinions are gathered, but on the whole it’s clear that the level of suspicion of the press, as well as government and security officials, is high. And with all that’s going on it’s not unfounded suspicion.
There are still a multitude of ...
Soldier Beheaded in Broad Daylight Machete Attack
2013 05 23
Woolwich attack: terrorist proclaimed ’an eye for an eye’ after attack
A British soldier has been butchered on a busy London street by two Islamist terrorists, one of whom proclaimed afterwards: “An eye for an eye and a tooth for a tooth.”
In the first terrorist murder on the British mainland since the 7/7 suicide bombings of 2005, the men attempted ...
Ciudad Blanca Found? The lost city in Honduras
2013 05 23
Explorers have been searching on foot for Honduras’s mythical city for generations. Now, they seem to have found it from a tiny Cessna airplane, aided by million-dollar technology.
Is the fabled lost city of Honduras hiding beneath the dense jungle canopy?
The Mosquitia rain forests of Honduras and Nicaragua are, to put it mildly, thick jungle. As one travel guide notes, "While ...
Cheetah-bot races into your post-apocalyptic nightmares
2013 05 23
An ongoing robotics project at MIT aiming to recreate the gait of a cheetah is sharing a new video showing off the latest progress. There’s a long way to go before anyone would call it catlike, but it’s impressive nevertheless.
The Biomimetic Robotics Lab at MIT is attempting to create things much like those being made by the more well-known ...
When an Army of Artists Fooled Hitler
2013 05 23
Shortly after the D-Day invasion on June 6, 1944, two Frenchmen on bicycles managed to cross the perimeter of the United States Army’s 23rd Headquarters Special Troops and what they saw astounded them. Four American soldiers had picked up a 40-ton Sherman tank and were turning it in place.
Soldier Arthur Shilstone says, “They looked at me, and they were ...
|More News » |